Peregrine Pharma (PPHM) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents	44.2M
Trade and other receivables, net	7.54M
Government contract receivables
Inventories, net	25.27M
Prepaid expenses and other current assets, net	1.24M
Total current assets	78.24M
Property, net	24.26M
Other assets	2.5M
TOTAL ASSETS	105.6M
Accounts payable	9.1M
Accrued clinical trial and related fees	6.58M
Accrued payroll and related costs	3.65M
Notes payable, current portion and net of discount
Deferred revenue	21.53M
Customer deposits	21.73M
Other current liabilities	669K
Total current liabilities	63.26M
Deferred revenue
Other long-term liabilities
Commitments and contingencies	0
Preferred stock-$0.001 par value; authorized 5,000,000 shares; non-voting; nil shares outstanding	2K
Common stock-$0.001 par value; authorized 325,000,000 shares; outstanding – 71,749,718 and 69,837,142, respectively
Additional paid-in capital	561.02M
Accumulated deficit	-520.33M
Total stockholders’ equity	40.93M
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	105.6M

Entities mentioned with PPHM

View All Entities